Status:
COMPLETED
PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Hoffmann-La Roche
Conditions:
Transplantation, Liver
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to measure the amount of MMF and tacrolimus concentration in the blood at a given time. Currently MMF is ordered as a set dose and tacrolimus is given based on body weight...
Detailed Description
The purpose of this study is to measure the amount of MMF and tacrolimus concentration in the blood at a given time. Currently MMF is ordered as a set dose and tacrolimus is given based on body weight...
Eligibility Criteria
Inclusion
- Adult
- Female patients
- Negative pregnancy test
- Willing for contraception during the study period and 6 weeks after study
Exclusion
- Serum Creatinine \> 2.5 mg/dl
- On Dialysis
- HIV +ve
- Re-transplantation
- On Ventilator
- Multi-organ Transplant
- Platelets \< 50,000
- WBC \< 2,500
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00178425
Start Date
January 1 2005
End Date
June 1 2006
Last Update
April 19 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States, 14642